Research
Compounded vs. brand-name GLP-1s: What the data says about efficacy
A deep dive into the clinical evidence comparing compounded semaglutide formulations with brand-name alternatives.
Insights
Research, guides, and analysis to help you navigate the peptide therapy landscape.
Guide
The complete guide to choosing a telehealth provider for peptide therapy
What to look for, what to avoid, and how to evaluate whether a provider is right for you.
Price Tracking
April 2026 price report: Compounded semaglutide drops below $100/mo
Our monthly price tracker shows continued price declines across major providers.
Industry
FDA compounding regulations: What changed in Q1 2026 and what it means for patients
A summary of the latest regulatory updates affecting compounded peptide access.
Guide
BPC-157 explained: What is it, how does it work, and who should consider it?
Everything you need to know about the recovery peptide gaining mainstream attention.
Research
Tirzepatide vs. semaglutide: Head-to-head comparison of outcomes data
A review of published clinical trials comparing the two most popular GLP-1 receptor agonists.